

Boiron is a Homeopathy company and has developed an app for iOS users Om_om_mo. Among its major competitors, Boiron is ranked in 2nd place for NPS while Weleda is 1st, and bioMerieux is 3rd.
Boiron's Net Promoter Score (NPS) is a 100 with 100% Promoters, 0% Passives, and 0% Detractors. Net Promoter Score tracks whether Boiron's customers would recommend using the product based on a scale of -100 to 100.
| 100% | Promoters |
|---|---|
| 0% | Passives |
| 0% | Detractors |
| Summary | Date | Score |
|---|---|---|
Oct 2023 100 | Oct 2023 | 100 |
Boiron is ranked first for NPS among its competitors. Alnylam Pharmaceuticals and AbbVie come in second and third, with Sanofi coming in at #4.
![]() Boiron | ![]() AbbVie | ![]() Sanofi | ![]() Alnylam Pharmaceuticals | |
| Global Ranking | #- | #321 | #- | #- |
| NPS | 100 | 22 | 21 | 24 |
| Social Sentiment Calculated by analyzing social media and other online mentions | - | Neutral | Neutral | Neutral |
| Valuation Updated every 24 hours for public companies | - | $190.99B | $129.27B | $24.72B |
Net Promoter Score (NPS) is a management tool that can be used to gauge the satisfaction of a firm's customer relationships. NPS has been widely adopted as a key metric often linked to the revenue potential of a company’s product or service. The metric is based on customer responses to the question: "On a scale of 0 to 10, how likely are you to recommend the product to a friend?"
Those who respond with a score of 9 to 10 are known as Promoters, and are widely associated with behaviors that create value, including actively encouraging others to use the product or service. Those who respond with a score of 7 or 8 are categorized as Passives, and they are believed to be less likely to exhibit the value-creation traits of Promoters having a largely neutral effect on other consumers. Detractors are those who fall in the score range of 0 to 6 and represent dissatisfied customers of the product sometimes actively recommending against using the product.
Compared to its competitors, Boiron's NPS is rated right above bioMerieux, and is preceded by Weleda.
| COMPANY | NPS Score | |
|---|---|---|
![]() | Weleda | 100 |
![]() | Boiron | 100 |
![]() | bioMerieux | 40 |
![]() | Alnylam Pharmaceuticals | 24 |
![]() | AbbVie | 22 |
![]() | Sanofi | 21 |
![]() | Boehringer Ingelheim Pharmaceuticals | N/A |